Legal Representation
Attorney
JUSTIN D. CARE
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 31, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 31, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 31, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 29, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| May 29, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 29, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 29, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 12, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 27, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 12, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 23, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 22, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 23, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 23, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 23, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 23, 2022 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 22, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 4, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
crude drugs in the nature of pharmaceutical preparations for the treatment of rare metabolic diseases, rare liver diseases, rare kidney diseases, rare complement-mediated diseases and rare tumors; mouthwashes for medical purposes; enzyme preparations for medical purposes; biological preparations for medical purposes, namely, pharmaceutical preparations for the treatment of rare metabolic diseases, rare liver diseases, rare kidney diseases, rare complement-mediated diseases and rare tumors; drugs for medical purposes, namely, for the treatment of rare metabolic diseases, rare liver diseases, rare kidney diseases, rare complement-mediated diseases and rare tumors; chemico-pharmaceutical preparations for the treatment of rare metabolic diseases, rare liver diseases, rare kidney diseases, rare complement-mediated diseases and rare tumors; diagnostic preparations for medical purposes; nutritional supplements; medicines for human purposes for the treatment of rare metabolic diseases, rare liver diseases, rare kidney diseases, rare complement-mediated diseases and rare tumors; medicated tonics for the treatment of rare metabolic diseases, rare liver diseases, rare kidney diseases, rare complement-mediated diseases and rare tumors
Additional Information
Design Mark
The mark consists of the word "CANBRIDGE" positioned above a horizontal line with Chinese characters underneath. To the left appears a stylized droplet shape.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
CAN BRIDGE
Other
The non-Latin characters in the mark transliterate to "BEIHAI KANG CHENG" and this means "Beihai healthy success" in English.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CHINESE CHARACTERS THAT CORRESPOND TO BEIHAI KANG"